Havdrup, Denmark

Jan Lindy Sørensen


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Brøndby, DK (2007)
  • Havdrup, DK (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Jan Lindy Sørensen: Pioneering Advances in Pharmaceutical Chemistry

Introduction

Jan Lindy Sørensen, hailing from Havdrup, Denmark, is a renowned inventor known for his significant contributions to pharmaceutical chemistry. With a robust portfolio featuring two patents, Sørensen's work exemplifies the innovative spirit that drives advancements in the treatment of various diseases.

Latest Patents

Sørensen's latest patents showcase his expertise and innovative approach. The first patent, titled "Method of acylating a peptide or protein," describes a method for selectively acylating an amino group in a peptide or protein that possesses two or more reactive nucleophilic functional groups. This technique promises to enhance the specificity and efficacy of peptide-based therapeutics.

The second patent focuses on "Substituted piperazines and diazepanes." This novel class of compounds includes pharmaceutical compositions that engage the histamine H3 receptor. The application of these compounds is particularly promising for treating diseases and disorders where interaction with the histamine H3 receptor proves beneficial, marking a significant stride forward in the development of targeted therapies.

Career Highlights

Jan Lindy Sørensen is a valued member of Novo Nordisk A/S, a leading global healthcare company founded in Denmark. His work at Novo Nordisk places him at the forefront of technological advancements in the healthcare field. His patents not only emphasize his creativity but also reflect the company's commitment to innovation in the pharmaceutical industry.

Collaborations

Throughout his career, Sørensen has collaborated with esteemed colleagues, including Florencio Zaragoza Dorwald and Knud Erik Andersen. These partnerships have contributed to the development of groundbreaking solutions and have enriched the collaborative environment within their research teams.

Conclusion

Jan Lindy Sørensen's contributions to pharmaceutical chemistry through his innovative methods and novel compounds highlight the critical role of inventors in advancing medical science. As he continues to push the boundaries of research, Sørensen remains a pivotal figure at Novo Nordisk, where his work promises to yield impactful treatments for a range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…